NEW! This past week, we added 1 new trial, we updated information on 2 other trials, and we've added 11 other pieces of information. The drugs with important additions and changes are dalfampridine, dimethyl fumarate, fingolimod, interferon beta-1a, interferon beta-1b, mitoxantrone, natalizumab, and teriflunomide.
We've also added a new entry for ATX-MS-1467, which contains information on 3 trials as well as 23 other pieces of information.
In summary, for the month of October we added 6 new trials, we updated information on 8 other trials, and we added 85 other pieces of information. The drugs with important additions and changes are ATX-MS-1467, daclizumab, dalfampridine, dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1a, interferon beta-1b, laquinimod, masitinib, mitoxantrone, natalizumab, rituximab, and teriflunomide. |
No comments:
Post a Comment